PMID: 8607595Apr 1, 1996Paper

Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources

Annals of Internal Medicine
J SeamanB L Herwaldt

Abstract

1) To determine the proportions of patients with visceral leishmaniasis who had various treatment outcomes when cared for under wartime conditions and with limited resources and 2) to identify patient characteristics associated with the outcomes. Cohort study. Médecins sans Frontières-Holland's treatment center in Duar, Western Upper Nile Province, an area in southern Sudan that has been severely affected by Sudan's civil war and a massive epidemic of visceral leishmaniasis. 3076 consecutive patients who had visceral leishmaniasis, were admitted to the treatment center the first year the center was operational (August 1990 to July 1991), and were treated with the pentavalent antimonial compound sodium stibogluconate. Patient characteristics on admission and four mutually exclusive treatment outcomes (default during first admission, death during first admission, discharge and readmission for retreatment [relapse], and discharge and no readmission for retreatment [successful treatment]). The patients had a median age of 15 years and were notably anemic (median hemoglobin level, 77g/L) and malnourished (median body mass index of adults [> or = 18 years of age], 15.2 kg/m2); most (91.0%) had been sick less than 5 months. Although p...Continue Reading

Citations

Sep 2, 2011·Parasitology Research·Samar N El-BeshbishiGoman A El-Ganainy
Jul 6, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T WeitzelUNKNOWN Surveillance Importierter Infektionen in Deutschland (SIMPID) Surveillance Network
Nov 30, 2000·Current Infectious Disease Reports·R D PearsonS M Jeronimo
Jan 31, 2002·Transactions of the Royal Society of Tropical Medicine and Hygiene·K RitmeijerR N Davidson
May 24, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·E E Zijlstra, A M el-Hassan
Aug 9, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·P Desjeux
Jul 1, 1997·Transactions of the Royal Society of Tropical Medicine and Hygiene·C BoriesP N Bories
Dec 16, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·O F OsmanP A Kager
Aug 2, 2002·The Lancet Infectious Diseases·Philippe J GuerinAnthony D M Bryceson
Oct 17, 2007·Nature Reviews. Microbiology·François ChappuisMarleen Boelaert
Dec 10, 1999·The New England Journal of Medicine·T K JhaJ Berman
Dec 10, 1999·The New England Journal of Medicine·B L Herwaldt
Nov 29, 2002·The New England Journal of Medicine·Henry W Murray
May 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B G MarshallI Müller
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S SundarH W Murray
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Simon CollinClive Davies
Aug 21, 2013·The Journal of Antimicrobial Chemotherapy·Kevin J PeineEric M Bachelder
Jun 15, 2010·PLoS Neglected Tropical Diseases·Stanislaw GorskiRobert N Davidson
Nov 13, 2010·PLoS Neglected Tropical Diseases·Márcia Jaqueline Alves de Queiroz SampaioJailson B Correia
Feb 22, 2012·PLoS Neglected Tropical Diseases·Valdelaine Etelvina Miranda de AraújoMariângela Carneiro
Apr 20, 2014·PLoS Neglected Tropical Diseases·Gláucia F CotaAna Rabello
May 3, 2014·PLoS Neglected Tropical Diseases·Caspar J HodiamontTom van Gool
Jul 8, 2010·Journal of Global Infectious Diseases·E M Moore, D N Lockwood
Nov 1, 2011·Clinical Medicine : Journal of the Royal College of Physicians of London·Elinor M Moore, Diana N Lockwood
Apr 7, 2006·Expert Review of Anti-infective Therapy·Margriet den Boer, Robert N Davidson
Aug 28, 2009·Expert Opinion on Emerging Drugs·Margriet Leontine den BoerManica Balasegaram
Nov 22, 2012·Expert Opinion on Emerging Drugs·Manica BalasegaramFrançois Chappuis
Feb 27, 2010·The Lancet Infectious Diseases·Johan van GriensvenMarleen Boelaert
Jun 26, 2009·Tropical Medicine & International Health : TM & IH·Yolanda MuellerFrançois Chappuis
Jul 19, 2003·Tropical Medicine & International Health : TM & IH·Suzi LyonsJean Long
Dec 15, 2010·Tropical Medicine & International Health : TM & IH·Maia KajaiaLouise-Anne McNutt
Aug 11, 2015·Pathogens and Global Health·Marta DriemeierAnamaria Mello Miranda Paniago
Oct 8, 1999·Lancet·B L Herwaldt
Jun 5, 2002·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Gjeorgjina LitaMira Basha
Feb 17, 2001·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·H W Murray
Dec 17, 2014·PLoS Neglected Tropical Diseases·Wendel Coura-VitalMariângela Carneiro
Dec 22, 2016·Revista Da Sociedade Brasileira De Medicina Tropical·Dorcas Lamounier CostaCarlos Henrique Nery Costa
May 14, 2014·Memórias do Instituto Oswaldo Cruz·Abdallah Mohammed SamyMohamed Amin Kenawy
Aug 31, 2010·Revista Da Sociedade Brasileira De Medicina Tropical·Carlos Henrique Nery CostaLoryenne Santos Santos
Mar 13, 2014·The American Journal of Tropical Medicine and Hygiene·Joyce M SilvaCarlos H N Costa
Mar 4, 2003·Revista Da Sociedade Brasileira De Medicina Tropical·Mácia A SantosCarlos H N Costa
Dec 17, 2008·Cadernos de saúde pública·Carlos Henrique Nery Costa
Sep 20, 2000·Tropical Medicine & International Health : TM & IH·O F OsmanL Oskam
Oct 3, 2017·PLoS Neglected Tropical Diseases·Suzette S KäminkKoert Ritmeijer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tropical Medicine & International Health : TM & IH
Yolanda MuellerFrançois Chappuis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Simon CollinClive Davies
PLoS Neglected Tropical Diseases
Márcia Jaqueline Alves de Queiroz SampaioJailson B Correia
© 2021 Meta ULC. All rights reserved